$724M
Reported book value
| # | Security | Shares | Share Δ QoQ | Value | % of book |
|---|---|---|---|---|---|
| 1 | PTCT Ptc Therapeutics Inc | 918,846 | −0.3% | $75M | 10.4% |
| 2 | ACAD Acadia Pharmaceuticals Inc | 2.9M | −0.3% | $72M | 10.0% |
| 3 | INSM Insmed Inc | 413,980 | −0.3% | $44M | 6.1% |
| 4 | MIRM Mirum Pharmaceuticals Inc | 348,808 | +7.3% | $41M | 5.6% |
| 5 | ANAB Anaptysbio Inc | 603,489 | −5.4% | $41M | 5.6% |
| 6 | BMRN Biomarin Pharmaceutical Inc | 682,777 | −0.4% | $39M | 5.4% |
| 7 | DYN Dyne Therapeutics Inc | 1.6M | −0.3% | $37M | 5.1% |
| 8 | UTHR United Therapeutics Corp Del | 62,587 | −0.4% | $34M | 4.7% |
| 9 | IRON Disc Medicine Inc | 416,646 | +3.7% | $30M | 4.2% |
| 10 | BIIB Biogen Inc | 140,279 | −0.3% | $30M | 4.2% |
| 11 | IOVA Iovance Biotherapeutics Inc | 5.3M | −16.6% | $22M | 3.0% |
| 12 | RARE Ultragenyx Pharmaceutical In | 596,495 | +0.0% | $20M | 2.8% |
| 13 | NVCR Novocure Ltd | 1.3M | +0.0% | $19M | 2.7% |
| 14 | SNDX Syndax Pharmaceuticals Inc | 864,986 | +0.0% | $19M | 2.6% |
| 15 | ANNX Annexon Inc | 2.9M | +0.0% | $17M | 2.3% |
| 16 | BCAX Bicara Therapeutics Inc | 550,408 | +0.0% | $16M | 2.3% |
| 17 | CDNA Caredx Inc | 531,870 | +0.0% | $15M | 2.1% |
| 18 | CLDX Celldex Therapeutics Inc New | 399,856 | +34.9% | $15M | 2.1% |
| 19 | CMPX Compass Therapeutics Inc | 5.8M | +285.1% | $13M | 1.8% |
| 20 | ALKS Alkermes Plc | 242,560 | +0.0% | $13M | 1.8% |
| 21 | TRAX First Tracks Biotherapeutics | 603,489 | — | $12M | 1.7% |
| 22 | PRTA Prothena Corp Plc | 1.1M | −5.4% | $11M | 1.5% |
| 23 | TVTX Travere Therapeutics Inc | 167,525 | −27.3% | $10M | 1.3% |
| 24 | TSHA Taysha Gene Therapies Inc | 1.4M | +0.0% | $9M | 1.3% |
| 25 | ACRS Aclaris Therapeutics Inc | 1.6M | +0.0% | $9M | 1.2% |
| 26 | AGIO Agios Pharmaceuticals Inc | 213,601 | +0.0% | $8M | 1.1% |
| 27 | CAPR Capricor Therapeutics Inc | 229,763 | +0.0% | $6M | 0.8% |
| 28 | ALGN Align Technology Inc | 31,389 | −24.4% | $5M | 0.7% |
| 29 | ORKA Oruka Therapeutics Inc | 33,546 | −44.1% | $3M | 0.4% |
| 30 | XENE Xenon Pharmaceuticals Inc | 51,345 | +0.0% | $3M | 0.4% |
| 31 | NBIX Neurocrine Biosciences Inc | 18,117 | +0.0% | $3M | 0.4% |
| 32 | EW Edwards Lifesciences Corp | 33,640 | +0.0% | $3M | 0.4% |
| 33 | STOK Stoke Therapeutics Inc | 84,631 | +0.0% | $3M | 0.4% |
| 34 | CYTK Cytokinetics Inc | 32,195 | +0.0% | $3M | 0.4% |
| 35 | PYXS Pyxis Oncology Inc | 864,277 | −14.5% | $3M | 0.4% |
| 36 | EHTH Ehealth Inc | 1.5M | +0.0% | $2M | 0.3% |
| 37 | CRSP Crispr Therapeutics Ag | 39,605 | +0.0% | $2M | 0.3% |
| 38 | SGMT Sagimet Biosciences Inc | 250,000 | — | $2M | 0.3% |
| 39 | NUVB Nuvation Bio Inc | 326,609 | −35.8% | $2M | 0.3% |
| 40 | BNTX Biontech Se | 19,614 | +0.0% | $2M | 0.3% |
| 41 | CMPS Compass Pathways Plc | 115,616 | +0.0% | $2M | 0.2% |
| 42 | HUM Humana Inc | 3,985 | +0.0% | $2M | 0.2% |
| 43 | NAMS Newamsterdam Pharma Company | 44,359 | — | $2M | 0.2% |
| 44 | VSTM Verastem Inc | 309,685 | +25.8% | $1M | 0.2% |
| 45 | MDGL Madrigal Pharmaceuticals Inc | 1,787 | +0.0% | $959,530 | 0.1% |
| 46 | URGN Urogen Pharma Ltd | 24,500 | +0.0% | $901,600 | 0.1% |
| 47 | BCYC Bicycle Therapeutics Plc | 201,890 | +0.0% | $856,014 | 0.1% |
| 48 | XERS Xeris Biopharma Holdings Inc | 104,410 | +0.0% | $826,927 | 0.1% |
| 49 | ABEO Abeona Therapeutics Inc | 108,865 | +0.0% | $672,786 | 0.1% |
| 50 | INSPIRE MED SYS INC Inspire Med Sys Inc | 8,772 | +0.0% | $391,319 | 0.1% |